Explore UAB

POISE LogoMission & Vision

The Pediatric Office for Improvement Science was created to realize improvement in patient outcomes for children across the state of Alabama by connecting departmental resources with divisional stakeholders, sharing opportunities for education and training, and advancing the quality of care using fundamentals of improvement science. 

   

QI Directors

Adolfo Molina, MD, MSHQS

Adolfo Molina, MD, MSHQS

Emily Smitherman, MD

Emily Smitherman, MD

QI Faculty

Physician Quality Officers with the UAB Department of Pediatrics are established leaders in quality improvement informed by formalized training and dedication to improvement within and beyond their subspecialty. Through their engagement with the POISE office they will serve as resources for education and coaching to help advance the academic productivity of quality work across the Department. 

Amy Cajacob, MD

Amy Cajacob, MD

Nicholas Cajacob, MD

Nicholas Cajacob, MD

David Galloway, MD

David Galloway, MD

Samantha Hanna, MD

Samantha Hanna, MD

Rachel Kassel, MD

Rachel Kassel, M.D.

Ashley Moellinger, NP

Ashley Moellinger, NP

Jeremy Loberger, MD

Jeremy Loberger, MD

Jessica Schmitt, MD

Jessica Schmitt, MD

Clinical Outcomes Coordinator

Mahek Virani, MPH

Mahek Virani, MPH

Program Coordinator

Anne Kinyua

 Anne Kinyua

QI Resources

Past Successes

  • Working Toward Viral Suppression and retention in care

    Working Toward Viral Suppression and retention in care

    Project Members: Claudette Poole, Celia Hutto, Audrey Lloyd, Heather Reylea, Christa Nevin, Sheila Stills, Lori Mills, Lauren Marefka, Nanyamke Foreman, Andy Yousef, Dayna Cook

    About the Initiative: The goal in HIV care is to achieve sustained virologic suppression. By natioanl standards, a suppressed viral load is considered a viral load of < 200 copies/mL. Patients who are able to keep their viral load < 200 copies/mL have a much better prognosis and much lower risk of transmission. The factor that is most closely correlated to achieving sustained virologic suppression is remaining engaged in clinical care.

    SMART Aim: For virologic suppression: the goal is to increase our percentage of patients with a viral load of < 200 from 81% to above the national percentage of 87% from 10/1/ 2022 to December 1, 2023